Cockayne syndrome group B (CSB) protein: At the crossroads of transcriptional networks

Mechanisms of Ageing and Development

Volumn 134, Issue 5-6, 2013, Pages 234-242

  Vélez Cruz, Renier ^a,b   Egly, Jean Marc ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Premature ageing; Progeria; Transcription coupled repair; Transcriptional dysregulation; Xeroderma pigmentosum

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CELL NUCLEUS RECEPTOR; CSB PROTEIN; GROWTH FACTOR; GROWTH HORMONE; PROTEIN P53; RIBOSOME DNA; SOMATOMEDIN C; TRANSCRIPTION FACTOR IIH; UNCLASSIFIED DRUG;

AGING; ARTICLE; BONE DISEASE; CACHEXIA; CELL HYPOXIA; CLINICAL FEATURE; COCKAYNE SYNDROME; CSA GENE; CSB GENE; DEVELOPMENTAL DISORDER; DNA DAMAGE; DNA TRANSCRIPTION; DWARFISM; EXCISION REPAIR; GENE MUTATION; GENE PRODUCT; GENETIC DISORDER; GENETIC TRANSCRIPTION; GROWTH DISORDER; HEARING IMPAIRMENT; HOUSEKEEPING GENE; HUMAN; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PHOTOSENSITIVITY; PREMATURE AGING; PRIORITY JOURNAL; ULTRAVIOLET RADIATION;

ANIMALS; CELL HYPOXIA; COCKAYNE SYNDROME; DNA DAMAGE; DNA HELICASES; DNA REPAIR; DNA REPAIR ENZYMES; DNA, RIBOSOMAL; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MICE; PROTEINS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84878014180     PISSN: 00476374     EISSN: 18726216     Source Type: Journal    
DOI: 10.1016/j.mad.2013.03.004     Document Type: Article

References (110)

1. Andressoo J.O., Mitchell J.R., de Wit J., Hoogstraten D., Volker M., Toussaint W., Speksnijder E., Beems R.B., Van Steeg H., Jans J., de Zeeuw C.I., Jaspers N.G.J., Raams A., Lehmann A.R., Vermeulen W., Hoeijmakers J.H.J., van der Horst G.T.J. An Xpd mouse model for the combined xeroderma pigmentosum/Cockayne syndrome exhibiting both cancer predisposition and segmental progeria. Cancer Cell 2006, 10:121-132.
2. Andressoo J.O., Weeda G., de Wit J., Mitchell J.R., Beems R.B., Van Steeg H., van der Horst G.T.J., Hoeijmakers J.H. An Xpb mouse model for combined xeroderma pigmentosum and Cockayne syndrome reveals progeroid features upon further attenuation of DNA repair. Molecular and Cellular Biology 2009, 29:1276-1290.
3. Anindya R., Mari P.-O., Kristensen U., Kool H., Giglia-Mari G., Mullenders L.H., Fousteri M., Vermeulen W., Egly J.-M., Svejstrup J.Q. A ubiquitin-binding domain in Cockayne syndrome B required for transcription-coupled nucleotide excision repair. Molecular Cell 2010, 38:637-648.
4. Balajee A.S., May A., Dianov G.L., Friedberg E.C., Bohr V.A. Reduced RNA polymerase II transcription in intact and permeabilized Cockayne syndrome group B cells. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:4306-4311.
5. Balajee A.S., Proietti De Santis L., Brosh R.M., Selzer R., Bohr V.A. Role of the ATPase domain of the Cockayne syndrome group B protein in UV induced apoptosis. Oncogene 2000, 19:477-489.
6. Beckerman R., Prives C. Transcriptional regulation by P53. Cold Spring Harbor Perspectives in Biology 2010, 2:a000935.
7. 2 availability on human cancer. Nature Reviews Cancer 2008, 8:967-975.
8. Bradsher J., Auriol J., Proietti De Santis L., Iben S., Vonesch J.L., Grummt I., Egly J.M. CSB is a component of RNA pol I transcription. Molecular Cell 2002, 10:819-829.
9. Bregman D.B., Halaban R., van Gool A.J., Henning K.A., Friedberg E.C., Warren S.L. UV-induced ubiquitination of RNA polymerase II: a novel modification deficient in Cockayne syndrome cells. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:11586-11590.
10. Brooks P.J. The 8,5'-cyclopurine-2'-deoxynucleosides: candidate neurodegenerative DNA lesions in xeroderma pigmentosum, and unique probes of transcription and nucleotide excision repair. DNA Repair 2008, 7:1168-1179.
11. Broughton B.C., Thompson A.F., Harcourt S.A., Vermeulen W., Hoeijmakers J.H., Botta E., Stefanini M., King M.D., Weber C.A., Cole J. Molecular and cellular analysis of the DNA repair defect in a patient in xeroderma pigmentosum complementation group D who has the clinical features of xeroderma pigmentosum and Cockayne syndrome. American Journal of Human Genetics 1995, 56:167-174.
12. Caputo M., Frontini M., Vélez-Cruz R., Nicolai S., Prantera G., Proietti-De-Santis L. The CSB repair factor is overexpressed in cancer cells, increases apoptotic resistance, and promotes tumor growth. DNA Repair 2013, 12:293-299.
13. Charlet-Berguerand N., Feuerhahn S., Kong S.E., Ziserman H., Conaway J.W., Conaway R., Egly J.-M. RNA polymerase II bypass of oxidative DNA damage is regulated by transcription elongation factors. EMBO Journal 2006, 25:5481-5491.
14. Citterio E., Rademakers S., van der Horst G.T., van Gool A.J., Hoeijmakers J.H., Vermeulen W. Biochemical and biological characterization of wild-type and ATPase-deficient Cockayne syndrome B repair protein. Journal of Biological Chemistry 1998, 273:11844-11851.
15. Citterio E., Van Den Boom V., Schnitzler G., Kanaar R., Bonte E., Kingston R.E., Hoeijmakers J.H., Vermeulen W. ATP-dependent chromatin remodeling by the Cockayne syndrome B DNA repair-transcription-coupling factor. Molecular and Cellular Biology 2000, 20:7643-7653.
16. Cleaver J.E., Hefner E., Laposa R.R., Karentz D., Marti T. Cockayne syndrome exhibits dysregulation of p21 and other gene products that may be independent of transcription-coupled repair. Neuroscience 2007, 145:1300-1308.
17. Cleaver J.E., Lam E.T., Revet I. Disorders of nucleotide excision repair: the genetic and molecular basis of heterogeneity. Nature Reviews Genetics 2009, 10:756-768.
18. Cleaver J.E., Revet I. Clinical implications of the basic defects in Cockayne syndrome and xeroderma pigmentosum and the DNA lesions responsible for cancer, neurodegeneration and aging. Mechanisms of Ageing and Development 2008, 129:492-497.
19. Compe E., Egly J.-M. TFIIH: when transcription met DNA repair. Nature Reviews Molecular Cell Biology 2012, 13:343-354.
20. Cramers P., Verhoeven E.E., Filon A.R., Rockx D.A.P., Santos S.J., van der Leer A.A., Kleinjans J.C.S., van Zeeland A.A., Mullenders L.H.F. Impaired repair of ionizing radiation-induced DNA damage in Cockayne syndrome cells. Radiation Research 2011, 175:432-443.
21. Da Costa R.M.A., Riou L., Paquola A., Menck C.F.M., Sarasin A. Transcriptional profiles of unirradiated or UV-irradiated human cells expressing either the cancer-prone XPB/CS allele or the noncancer-prone XPB/TTD allele. Oncogene 2005, 24:1359-1374.
22. de Boer J., Andressoo J.O., de Wit J., Huijmans J., Beems R.B., Van Steeg H., Weeda G., van der Horst G.T.J., Van Leeuwen W., Themmen A.P.N., Meradji M., Hoeijmakers J.H.J. Premature aging in mice deficient in DNA repair and transcription. Science 2002, 296:1276-1279.
23. de Keizer P.L.J., Laberge R.-M., Campisi J. p53: pro-aging or pro-longevity?. Aging 2010, 2:377-379.
24. de Waard H., de Wit J., Andressoo J.O., van Oostrom C.T.M., Riis B., Weimann A., Poulsen H.E., Van Steeg H., Hoeijmakers J.H.J., van der Horst G.T.J. Different effects of CSA and CSB deficiency on sensitivity to oxidative DNA damage. Molecular and Cellular Biology 2004, 24:7941-7948.
25. de Waard H., de Wit J., Gorgels T.G.M.F., van den Aardweg G., Andressoo J.O., Vermeij M., Van Steeg H., Hoeijmakers J.H.J., van der Horst G.T.J. Cell type-specific hypersensitivity to oxidative damage in CSB and XPA mice. DNA Repair 2003, 2:13-25.
26. Dianov G.L, Houle J.F., Iyer N., Bohr V.A., Friedberg E.C. Reduced RNA polymerase II transcription in extracts of Cockayne syndrome and xeroderma pigmentosum/Cockayne syndrome cells. Nucleic Acids Research 1997, 25:3636-3642.
27. Dubaele S., Egly J.M. Cockayne syndrome, between transcription and DNA repair defects. Journal of the European Academy of Dermatology and Venereology 2002, 16:220-226.
28. Dubaele S., Proietti De Santis L., Bienstock R.J., Keriel A., Stefanini M., Houten B.V., Egly J.-M. Basal transcription defect discriminates between xeroderma pigmentosum and trichothiodystrophy in XPD patients. Molecular Cell 2003, 11:1635-1646.
29. Ellison A.R., Nouspikel T., Jaspers N.G., Clarkson S.G., Gruenert D.C. Complementation of transformed fibroblasts from patients with combined xeroderma pigmentosum-Cockayne syndrome. Experimental Cell Research 1998, 243:22-28.
30. Filippi S., Latini P., Frontini M., Palitti F., Egly J.-M., Proietti-De-Santis L. CSB protein is (a direct target of HIF-1 and) a critical mediator of the hypoxic response. EMBO Journal 2008, 27:2545-2556.
31. Fousteri M., Vermeulen W., van Zeeland A.A., Mullenders L.H.F. Cockayne syndrome A and B proteins differentially regulate recruitment of chromatin remodeling and repair factors to stalled RNA polymerase II in vivo. Molecular Cell 2006, 23:471-482.
32. Friedberg E.C., Aguilera A., Gellert M., Hanawalt P.C., Hays J.B., Lehmann A.R., Lindahl T., Lowndes N., Sarasin A., Wood R.D. DNA repair: from molecular mechanism to human disease. DNA Repair 2006, 5:986-996.
33. Frontini M., Proietti-De-Santis L. Cockayne syndrome B protein (CSB): linking p53, HIF-1 and p300 to robustness, lifespan, cancer and cell fate decisions. Cell Cycle 2009, 8:693-696.
34. Frontini M., Proietti-De-Santis L. Interaction between the Cockayne syndrome B and p53 proteins: implications for aging. Aging 2012, 4:89-97.
35. Gorgels T.G.M.F., Van Der Pluijm I., Brandt R.M.C., Garinis G.A., Van Steeg H., van den Aardweg G., Jansen G.H., Ruijter J.M., Bergen A.A.B., van Norren D., Hoeijmakers J.H.J., van der Horst G.T.J. Retinal degeneration and ionizing radiation hypersensitivity in a mouse model for Cockayne syndrome. Molecular and Cellular Biology 2007, 27:1433-1441.
36. Groisman R., Kuraoka I., Chevallier O., Gaye N., Magnaldo T., Tanaka K., Kisselev A.F., Harel-Bellan A., Nakatani Y. CSA-dependent degradation of CSB by the ubiquitin-proteasome pathway establishes a link between complementation factors of the Cockayne syndrome. Genes and Development 2006, 20:1429-1434.
37. Groisman R., Polanowska J., Kuraoka I., Sawada J.-I., Saijo M., Drapkin R., Kisselev A.F., Tanaka K., Nakatani Y. The ubiquitin ligase activity in the DDB2 and CSA complexes is differentially regulated by the COP9 signalosome in response to DNA damage. Cell 2003, 113:357-367.
38. Grummt I., Ladurner A.G. A metabolic throttle regulates the epigenetic state of rDNA. Cell 2008, 133:577-580.
39. Guarente L., Kenyon C. Genetic pathways that regulate ageing in model organisms. Nature 2000, 408:255-262.
40. Haigis M.C., Yankner B.A. The aging stress response. Molecular Cell 2010, 40:333-344.
41. Hanawalt P.C., Spivak G. Transcription-coupled DNA repair: two decades of progress and surprises. Nature Reviews Molecular Cell Biology 2008, 9:958-970.
42. Henning K.A., Li L., Iyer N., McDaniel L.D., Reagan M.S., Legerski R., Schultz R.A., Stefanini M., Lehmann A.R., Mayne L.V., Friedberg E.C. The Cockayne syndrome group A gene encodes a WD repeat protein that interacts with CSB protein and a subunit of RNA polymerase II TFIIH. Cell 1995, 82:555-564.
43. Hinkal G., Donehower L.A. How does suppression of IGF-1 signaling by DNA damage affect aging and longevity?. Mechanisms of Ageing and Development 2008, 129:243-253.
44. Ito S., Kuraoka I., Chymkowitch P., Compe E., Takedachi A., Ishigami C., Coin F., Egly J.-M., Tanaka K. XPG stabilizes TFIIH, allowing transactivation of nuclear receptors: implications for Cockayne syndrome in XP-G/CS patients. Molecular Cell 2007, 26:231-243.
45. Iyer N., Reagan M.S., Wu K.J., Canagarajah B., Friedberg E.C. Interactions involving the human RNA polymerase II transcription/nucleotide excision repair complex TFIIH, the nucleotide excision repair protein XPG, and Cockayne syndrome group B (CSB) protein. Biochemistry 1996, 35:2157-2167.
46. Jaarsma D., Van Der Pluijm I., de Waard M.C., Haasdijk E.D., Brandt R., Vermeij M., Rijksen Y., Maas A., Van Steeg H., Hoeijmakers J.H.J., van der Horst G.T.J. Age-related neuronal degeneration: complementary roles of nucleotide excision repair and transcription-coupled repair in preventing neuropathology. PLoS Genetics 2011, 7:e1002405.
47. Kamiuchi S., Saijo M., Citterio E., de Jager M., Hoeijmakers J.H.J., Tanaka K. Translocation of Cockayne syndrome group A protein to the nuclear matrix: possible relevance to transcription-coupled DNA repair. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:201-206.
48. Kenyon C. A conserved regulatory system for aging. Cell 2001, 105:165-168.
49. Keriel A., Stary A., Sarasin A., Rochette-Egly C., Egly J.M. XPD mutations prevent TFIIH-dependent transactivation by nuclear receptors and phosphorylation of RARalpha. Cell 2002, 109:125-135.
50. Kim J.-H., Workman J.L. Histone acetylation in heterochromatin assembly. Genes and Development 2010, 24:738-740.
51. Kraemer K.H., Patronas N.J., Schiffmann R., Brooks B.P., Tamura D., DiGiovanna J.J. Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome: a complex genotype-phenotype relationship. Neuroscience 2007, 145:1388-1396.
52. Kristensen, U., Epanchintsev, A., Rauschendorf, M.-A., Laugel, V., Stevnsner, T., Bohr, V.A., Coin, F., Egly, J.-M. Regulatory interplay of Cockayne syndrome B ATPase and stress-response gene ATF3 following genotoxic stress, submitted for publication, 1-10.
53. Kwon S.H., Workman J.L. HP1c casts light on dark matter. Cell Cycle 2011, 10:625-630.
54. Kyng K.J., Bohr V.A. Gene expression and DNA repair in progeroid syndromes and human aging. Ageing Research Reviews 2005, 4:579-602.
55. Lainé J.-P., Egly J.-M. Initiation of DNA repair mediated by a stalled RNA polymerase IIO. EMBO Journal 2006, 25:387-397.
56. Lake R.J., Basheer A., Fan H.-Y. Reciprocally regulated chromatin association of Cockayne syndrome protein B and p53 protein. Journal of Biological Chemistry 2011, 286:34951-34958.
57. Laposa R.R., Huang E.J., Cleaver J.E. Increased apoptosis, p53 up-regulation, and cerebellar neuronal degeneration in repair-deficient Cockayne syndrome mice. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:1389-1394.
58. Latini P., Frontini M., Caputo M., Gregan J., Cipak L., Filippi S., Kumar V., Vélez-Cruz R., Stefanini M., Proietti-De-Santis L. CSA and CSB proteins interact with p53 and regulate its Mdm2-dependent ubiquitination. Cell Cycle 2011, 10:3719-3730.
59. Laugel V., Dalloz C., Stary A., Cormier-Daire V., Desguerre I., Renouil M., Fourmaintraux A., Vélez-Cruz R., Egly J.-M., Sarasin A., Dollfus H. Deletion of 5' sequences of the CSB gene provides insight into the pathophysiology of Cockayne syndrome. European Journal of Human Genetics 2008, 16:320-327.
60. Lee S.-K., Yu S.-L., Prakash L., Prakash S. Requirement of yeast RAD2, a homolog of human XPG gene, for efficient RNA polymerase II transcription. Implications for Cockayne syndrome. Cell 2002, 109:823-834.
61. Lehmann A.R. The xeroderma pigmentosum group D (XPD) gene: one gene, two functions, three diseases. Genes and Development 2001, 15:15-23.
62. Ljungman M., Zhang F. Blockage of RNA polymerase as a possible trigger for U.V. light-induced apoptosis. Oncogene 1996, 13:823-831.
63. Ljungman M., Zhang F., Chen F., Rainbow A.J., McKay B.C. Inhibition of RNA polymerase II as a trigger for the p53 response. Oncogene 1999, 18:583-592.
64. Lomberk G., Wallrath L., Urrutia R. The heterochromatin protein 1 family. Genome Biology 2006, 7:228.
65. Lu H., Zawel L., Fisher L., Egly J.M., Reinberg D. Human general transcription factor IIH phosphorylates the C-terminal domain of RNA polymerase II. Nature 1992, 358:641-645.
66. Maier B., Gluba W., Bernier B., Turner T., Mohammad K., Guise T., Sutherland A., Thorner M., Scrable H. Modulation of mammalian life span by the short isoform of p53. Genes and Development 2004, 18:306-319.
67. Majmundar A.J., Wong W.J., Simon M.C. Hypoxia-inducible factors and the response to hypoxic stress. Molecular Cell 2010, 40:294-309.
68. Mayne L.V., Lehmann A.R. Failure of RNA synthesis to recover after UV irradiation: an early defect in cells from individuals with Cockayne's syndrome and xeroderma pigmentosum. Cancer Research 1982, 42:1473-1478.
69. McKay B.C., Chen F., Clarke S.T., Wiggin H.E., Harley L.M., Ljungman M. UV light-induced degradation of RNA polymerase II is dependent on the Cockayne's syndrome A and B proteins but not p53 or MLH1. Mutation Research 2001, 485:93-105.
70. McStay B., Grummt I. The epigenetics of rRNA genes: from molecular to chromosome biology. Annual Review of Cell and Developmental Biology 2008, 24:131-157.
71. Muftuoglu M., Sharma S., Thorslund T., Stevnsner T., Soerensen M.M., Brosh R.M., Bohr V.A. Cockayne syndrome group B protein has novel strand annealing and exchange activities. Nucleic Acids Research 2006, 34:295-304.
72. Murai M., Enokido Y., Inamura N., Yoshino M., Nakatsu Y., van der Horst G.T., Hoeijmakers J.H., Tanaka K., Hatanaka H. Early postnatal ataxia and abnormal cerebellar development in mice lacking Xeroderma pigmentosum Group A and Cockayne syndrome Group B DNA repair genes. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:13379-13384.
73. Nance M.A., Berry S.A. Cockayne syndrome: review of 140 cases. American Journal of Medical Genetics 1992, 42:68-84.
74. Nardo T., Oneda R., Spivak G., Vaz B., Mortier L., Thomas P., Orioli D., Laugel V., Stary A., Hanawalt P.C., Sarasin A., Stefanini M. A UV-sensitive syndrome patient with a specific CSA mutation reveals separable roles for CSA in response to UV and oxidative DNA damage. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:6209-6214.
75. Niedernhofer L.J., Bohr V.A., Sander M., Kraemer K.H. Xeroderma pigmentosum and other diseases of human premature aging and DNA repair: molecules to patients. Mechanisms of Ageing and Development 2011, 132:340-347.
76. Pagon R.A., Bird T.D., Dolan C.R., Stephens K., Adam M.P., Laugel V. Cockayne Syndrome 1993, University of Washington, Seattle, WA.
77. Proietti De Santis L., Garcia C.L., Balajee A.S., Brea Calvo G.T., Bassi L., Palitti F. Transcription coupled repair deficiency results in increased chromosomal aberrations and apoptotic death in the UV61 cell line, the Chinese hamster homologue of Cockayne's syndrome B. Mutation Research 2001, 485:121-132.
78. Proietti-De-Santis L., Drané P., Egly J.-M. Cockayne syndrome B protein regulates the transcriptional program after UV irradiation. EMBO Journal 2006, 25:1915-1923.
79. Proietti-De-Santis L., Garcia C.L., Balajee A.S., Latini P., Pichierri P., Nikaido O., Stefanini M., Palitti F. Transcription coupled repair efficiency determines the cell cycle progression and apoptosis after UV exposure in hamster cells. DNA Repair 2002, 1:209-223.
80. Revet I., Feeney L., Tang A.A., Huang E.J., Cleaver J.E. Dysmyelination not demyelination causes neurological symptoms in preweaned mice in a murine model of Cockayne syndrome. Proceedings of the National Academy of Sciences of the United States of America 2012, 109:4627-4632.
81. Rockx D.A., Mason R., van Hoffen A., Barton M.C., Citterio E., Bregman D.B., van Zeeland A.A., Vrieling H., Mullenders L.H. UV-induced inhibition of transcription involves repression of transcription initiation and phosphorylation of RNA polymerase II. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:10503-10508.
82. Rodier F., Campisi J., Bhaumik D. Two faces of p53: aging and tumor suppression. Nucleic Acids Research 2007, 35:7475-7484.
83. Saijo M., Hirai T., Ogawa A., Kobayashi A., Kamiuchi S., Tanaka K. Functional TFIIH is required for UV-induced translocation of CSA to the nuclear matrix. Molecular and Cellular Biology 2007, 27:2538-2547.
84. Schmitz K.-M., Schmitt N., Hoffmann-Rohrer U., Schäfer A., Grummt I., Mayer C. TAF12 recruits Gadd45a and the nucleotide excision repair complex to the promoter of rRNA genes leading to active DNA demethylation. Molecular Cell 2009, 33:344-353.
85. Selby C.P., Sancar A. Cockayne syndrome group B protein enhances elongation by RNA polymerase II. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:11205-11209.
86. Spivak G., Hanawalt P.C. Host cell reactivation of plasmids containing oxidative DNA lesions is defective in Cockayne syndrome but normal in UV-sensitive syndrome fibroblasts. DNA Repair 2006, 5:13-22.
87. Stevnsner T., Muftuoglu M., Aamann M.D., Bohr V.A. The role of Cockayne syndrome group B (CSB) protein in base excision repair and aging. Mechanisms of Ageing and Development 2008, 129:441-448.
88. -/- keratinocyte cultures. DNA Repair 2005, 4:1337-1344.
89. Tantin D. RNA polymerase II elongation complexes containing the Cockayne syndrome group B protein interact with a molecular complex containing the transcription factor IIH components xeroderma pigmentosum B and p62. Journal of Biological Chemistry 1998, 273:27794-27799.
90. Tantin D., Kansal A., Carey M. Recruitment of the putative transcription-repair coupling factor CSB/ERCC6 to RNA polymerase II elongation complexes. Molecular and Cellular Biology 1997, 17:6803-6814.
91. Thorslund T., von Kobbe C., Harrigan J.A., Indig F.E., Christiansen M., Stevnsner T., Bohr V.A. Cooperation of the Cockayne syndrome group B protein and poly(ADP-ribose) polymerase 1 in the response to oxidative stress. Molecular and Cellular Biology 2005, 25:7625-7636.
92. Troelstra C., Odijk H., de Wit J., Westerveld A., Thompson L.H., Bootsma D., Hoeijmakers J.H. Molecular cloning of the human DNA excision repair gene ERCC-6. Molecular and Cellular Biology 1990, 10:5806-5813.
93. Troelstra C., van Gool A., de Wit J., Vermeulen W., Bootsma D., Hoeijmakers J.H. ERCC6, a member of a subfamily of putative helicases, is involved in Cockayne's syndrome and preferential repair of active genes. Cell 1992, 71:939-953.
94. Tyner S.D., Venkatachalam S., Choi J., Jones S., Ghebranious N., Igelmann H., Lu X., Soron G., Cooper B., Brayton C., Park S.H., Thompson T., Karsenty G., Bradley A., Donehower L.A. p53 mutant mice that display early ageing-associated phenotypes. Nature 2002, 415:45-53.
95. van der Horst G.T., van Steeg H., Berg R.J., van Gool A.J., de Wit J., Weeda G., Morreau H., Beems R.B., van Kreijl C.F., de Gruijl F.R., Bootsma D., Hoeijmakers J.H. Defective transcription-coupled repair in Cockayne syndrome B mice is associated with skin cancer predisposition. Cell 1997, 89:425-435.
96. Van Der Pluijm I., Garinis G.A., Brandt R.M.C., Gorgels T.G.M.F., Wijnhoven S.W., Diderich K.E.M., de Wit J., Mitchell J.R., van Oostrom C., Beems R., Niedernhofer L.J., Velasco S., Friedberg E.C., Tanaka K., Van Steeg H., Hoeijmakers J.H.J., van der Horst G.T.J. Impaired genome maintenance suppresses the growth hormone - insulin-like growth factor 1 axis in mice with Cockayne syndrome. PLoS Biology 2007, 5:e2.
97. van Gool A.J., Citterio E., Rademakers S., van Os R., Vermeulen W., Constantinou A., Egly J.M., Bootsma D., Hoeijmakers J.H. The Cockayne syndrome B protein, involved in transcription-coupled DNA repair, resides in an RNA polymerase II-containing complex. EMBO Journal 1997, 16:5955-5965.
98. van Gool A.J., van der Horst G.T., Citterio E., Hoeijmakers J.H. Cockayne syndrome: defective repair of transcription?. EMBO Journal 1997, 16:4155-4162.
99. van Hoffen A., Kalle W.H., de Jong-Versteeg A., Lehmann A.R., van Zeeland A.A., Mullenders L.H. Cells from XP-D and XP-D-CS patients exhibit equally inefficient repair of UV-induced damage in transcribed genes but different capacity to recover UV-inhibited transcription. Nucleic Acids Research 1999, 27:2898-2904.
100. van Oosterwijk M.F., Filon R., de Groot A.J., van Zeeland A.A., Mullenders L.H. Lack of transcription-coupled repair of acetylaminofluorene DNA adducts in human fibroblasts contrasts their efficient inhibition of transcription. Journal of Biological Chemistry 1998, 273:13599-13604.
101. van Oosterwijk M.F., Versteeg A., Filon R., van Zeeland A.A., Mullenders L.H. The sensitivity of Cockayne's syndrome cells to DNA-damaging agents is not due to defective transcription-coupled repair of active genes. Molecular and Cellular Biology 1996, 16:4436-4444.
102. Vélez-Cruz R., Johnson D.G. E2F1 and p53 transcription factors as accessory factors for nucleotide excision repair. International Journal of Molecular Sciences 2012, 13:13554-13568.
103. Vélez-Cruz R., Zadorin A.S., Coin F., Egly J.-M. Sirt1 suppresses RNA synthesis after UV irradiation in combined xeroderma pigmentosum group D/Cockayne syndrome (XP-D/CS) cells. Proceedings of the National Academy of Sciences of the United States of America 2013, 110:E212-E220.
104. Wang X.W., Yeh H., Schaeffer L., Roy R., Moncollin V., Egly J.M., Wang Z., Freidberg E.C., Evans M.K., Taffe B.G. p53 modulation of TFIIH-associated nucleotide excision repair activity. Nature Genetics 1995, 10:188-195.
105. Wood R.D., Mitchell M., Sgouros J., Lindahl T. Human DNA repair genes. Science 2001, 291:1284-1289.
106. Xie W., Ling T., Zhou Y., Feng W., Zhu Q., Stunnenberg H.G., Grummt I., Tao W. The chromatin remodeling complex NuRD establishes the poised state of rRNA genes characterized by bivalent histone modifications and altered nucleosome positions. Proceedings of the National Academy of Sciences of the United States of America 2012, 109:8161-8166.
107. Yakar S., Adamo M.L. Insulin-like growth factor 1 physiology: lessons from mouse models. Endocrinology and Metabolism Clinics of North America 2012, 41:231-247. v.
108. Yu A., Fan H.Y., Liao D., Bailey A.D., Weiner A.M. Activation of p53 or loss of the Cockayne syndrome group B repair protein causes metaphase fragility of human U1, U2, and 5S genes. Molecular Cell 2000, 5:801-810.
109. Yuan X., Feng W., Imhof A., Grummt I., Zhou Y. Activation of RNA polymerase I transcription by Cockayne syndrome group B protein and histone methyltransferase G9a. Molecular Cell 2007, 27:585-595.
110. Zafeiriou D.I., Thorel F., Andreou A., Kleijer W.J., Raams A., Garritsen V.H., Gombakis N., Jaspers N.G., Clarkson S.G. Xeroderma pigmentosum group G with severe neurological involvement and features of Cockayne syndrome in infancy. Pediatric Research 2001, 49:407-412.